HPV

April 27, 2023

Trial combines novel therapies for head and neck cancer

Vanderbilt is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.

By Tom Wilemon
January 13, 2022

Study seeks to refine head and neck cancer treatment options

By Bill Snyder
A new robot with a flexible camera and three different surgical instruments will allow more targeted surgeries for patients with head and neck cancers.
October 21, 2021

New robot enhances accuracy of head, neck cancer surgeries

By Emily Stembridge
May 27, 2021

Vanderbilt-Ingram Cancer Center calls for action to get cancer-preventing HPV vaccination back on track

A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.

By VUMC News and Communications
February 5, 2020

Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

By Tom Wilemon
March 7, 2019

Symposium explores prevention of HPV-associated cancers

Physicians and researchers from across the country came to the Vanderbilt Symposium on HPV Infections and Associated Cancers on March 1 to discuss screening and prevention strategies for the human papillomavirus (HPV).

By Kelsey Herbers
March 8, 2018

Awareness, education goal of new HPV initiative

Vanderbilt is at the epicenter of a human papillomavirus (HPV)-associated cancer epidemic, according to Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology at Vanderbilt.
By Jessica Pasley
July 12, 2017

Conference to focus on link between viruses and cancer

The association between tobacco use and cancer is well known. But there are other risk factors for cancer that are less recognized, including the link between cancer and certain viruses.
By VUMC News and Communications
May 11, 2017

Researchers seek best ways to increase HPV vaccination rates

Tennessee has one of the lowest human papillomavirus (HPV) vaccination rates in the nation, and investigators at Vanderbilt University Medical Center (VUMC) are hoping to change this by improving the way medical providers present these vaccines to patients and by improving patient and patient family education.
By Jill Clendening
February 2, 2017

National Cancer Institute’s Lowy details HPV virus research efforts

Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection.
By VUMC News and Communications
January 17, 2017

Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country.
By VUMC News and Communications
February 4, 2016

VICC joins other major cancer centers in HPV vaccine campaign

In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.
By VUMC News and Communications
June 19, 2014

HPV-positive head and neck cancer patients may receive lower radiation dose

A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects.
By VUMC News and Communications